{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:49:22Z","timestamp":1790686162803,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["2KL2TR002547 PI: Dweik"],"award-info":[{"award-number":["2KL2TR002547 PI: Dweik"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11239-020-02344-9","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T05:07:26Z","timestamp":1606194446000},"page":"854-869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-1113","authenticated-orcid":false,"given":"Seth J.","family":"Rotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"issue":"17","key":"2344_CR1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354(17):1813\u20131826","journal-title":"N Engl J Med"},{"issue":"15","key":"2344_CR2","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1056\/NEJMp078166","volume":"357","author":"FR Appelbaum","year":"2007","unstructured":"Appelbaum FR (2007) Hematopoietic-cell transplantation at 50. N Engl J Med 357(15):1472\u20131475","journal-title":"N Engl J Med"},{"issue":"9","key":"2344_CR3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2017.05.035","volume":"23","author":"A D'Souza","year":"2017","unstructured":"D\u2019Souza A, Lee S, Zhu X, Pasquini M (2017) Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant 23(9):1417\u20131421","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2344_CR4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bbmt.2017.04.018","volume":"23","author":"P Khandelwal","year":"2017","unstructured":"Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ et al (2017) Hematopoietic stem cell transplantation activity in pediatric cancer between 2008 and 2014 in the United States: A center for international blood and marrow transplant research report. Biol Blood Marrow Transplant 23(8):1342\u20131349","journal-title":"Biol Blood Marrow Transplant"},{"key":"2344_CR5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MPH.0000000000001786","volume":"42","author":"M El-Shanshory","year":"2020","unstructured":"El-Shanshory M, Tolba O, El-Shafiey R, Mawlana W, Elgamasy M, Hablas N (2020) Cardiac iron overload by MRI in children with B-thalassemia major and its correlation with cardiac function by echocardiography. J Pediatr Hematol Oncol 42:398\u2013402","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"2344_CR6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2010-04-282095","volume":"116","author":"MT Gladwin","year":"2010","unstructured":"Gladwin MT, Barst RJ, Castro OL, Gordeuk VR, Hillery CA, Kato GJ et al (2010) Pulmonary hypertension and NO in sickle cell. Blood 116(5):852\u2013854","journal-title":"Blood"},{"issue":"2","key":"2344_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2017-02-767624","volume":"130","author":"O Niss","year":"2017","unstructured":"Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA et al (2017) Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. Blood 130(2):205\u2013213","journal-title":"Blood"},{"issue":"12","key":"2344_CR8","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2009-04-217455","volume":"115","author":"DJ Pennell","year":"2010","unstructured":"Pennell DJ, Porter JB, Cappellini MD, El-Beshlawy A, Chan LL, Aydinok Y et al (2010) Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. Blood 115(12):2364\u20132371","journal-title":"Blood"},{"issue":"7","key":"2344_CR9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/bmt.2015.11","volume":"50","author":"SJ Rotz","year":"2015","unstructured":"Rotz SJ, O\u2019Riordan MA, Kim C, de Lima M, Gladwin MT, Little JA (2015) Traffic Light: prognosis-based eligibility for clinical trials of hematopoietic SCT in adults with sickle cell anemia. Bone Marrow Transplant 50(7):918\u2013923","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2344_CR10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/pbc.25456","volume":"62","author":"TD Ryan","year":"2015","unstructured":"Ryan TD, Jefferies JL, Chin C, Sticka JJ, Taylor MD, Harris R et al (2015) Abnormal circumferential strain measured by echocardiography is present in patients with Shwachman-Diamond syndrome despite normal shortening fraction. Pediatr Blood Cancer 62(7):1228\u20131231","journal-title":"Pediatr Blood Cancer"},{"key":"2344_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/8904_2012_208","volume":"10","author":"L Schroeder","year":"2013","unstructured":"Schroeder L, Orchard P, Whitley CB, Berry JM, Tolar J, Miller W et al (2013) Cardiac ultrasound findings in infants with severe (Hurler phenotype) untreated mucopolysaccharidosis (MPS) type I. JIMD Rep 10:87\u201394","journal-title":"JIMD Rep"},{"key":"2344_CR12","unstructured":"D\u2019Souza A, Fretham C (2019) Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides, 2017. Center for International Blood and Marrow Transplant Research (CIBMTR). http:\/\/www.cibmtr.org. Accessed 30 2019"},{"issue":"1","key":"2344_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0046-8177(76)80004-4","volume":"7","author":"LM Buja","year":"1976","unstructured":"Buja LM, Ferrans VJ, Graw RG Jr (1976) Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol 7(1):17\u201345","journal-title":"Hum Pathol"},{"issue":"10","key":"2344_CR14","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","volume":"57","author":"B Cazin","year":"1986","unstructured":"Cazin B, Gorin NC, Laporte JP, Gallet B, Douay L, Lopez M et al (1986) Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer 57(10):2061\u20132069","journal-title":"Cancer"},{"issue":"5","key":"2344_CR15","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","volume":"68","author":"MA Goldberg","year":"1986","unstructured":"Goldberg MA, Antin JH, Guinan EC, Rappeport JM (1986) Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 68(5):1114\u20131118","journal-title":"Blood"},{"issue":"9","key":"2344_CR16","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/archinte.1984.00350210198035","volume":"144","author":"L Vaickus","year":"1984","unstructured":"Vaickus L, Letendre L (1984) Pericarditis induced by high-dose cytarabine therapy. Arch Intern Med 144(9):1868\u20131869","journal-title":"Arch Intern Med"},{"issue":"9","key":"2344_CR17","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/1097-0142(19911101)68:9<1910::AID-CNCR2820680911>3.0.CO;2-E","volume":"68","author":"SS Kanj","year":"1991","unstructured":"Kanj SS, Sharara AI, Shpall EJ, Jones RB, Peters WP (1991) Myocardial ischemia associated with high-dose carmustine infusion. Cancer 68(9):1910\u20131912","journal-title":"Cancer"},{"issue":"10","key":"2344_CR18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1701217","volume":"21","author":"A Olivieri","year":"1998","unstructured":"Olivieri A, Corvatta L, Montanari M, Brunori M, Offidani M, Ferretti GF et al (1998) Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. Bone Marrow Transplant 21(10):1049\u20131053","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2344_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10561-011-9248-2","volume":"13","author":"MA Cox","year":"2012","unstructured":"Cox MA, Kastrup J, Hrubisko M (2012) Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide. Cell Tissue Bank 13(2):203\u2013215","journal-title":"Cell Tissue Bank"},{"issue":"20","key":"2344_CR20","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.jacc.2017.09.1095","volume":"70","author":"HM Chang","year":"2017","unstructured":"Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ETH (2017) Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2. J Am Coll Cardiol 70(20):2552\u20132565","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2344_CR21","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","volume":"70","author":"HM Chang","year":"2017","unstructured":"Chang HM, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH (2017) Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1. J Am Coll Cardiol 70(20):2536\u20132551","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2344_CR22","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMra1100265","volume":"375","author":"JJ Moslehi","year":"2016","unstructured":"Moslehi JJ (2016) Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med 375(15):1457\u20131467","journal-title":"N Engl J Med"},{"issue":"3","key":"2344_CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11912-019-0774-6","volume":"21","author":"M Tuzovic","year":"2019","unstructured":"Tuzovic M, Mead M, Young PA, Schiller G, Yang EH (2019) Cardiac complications in the adult bone marrow transplant patient. Curr Oncol Rep 21(3):28","journal-title":"Curr Oncol Rep"},{"key":"2344_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-030-01322-6_12","volume-title":"Critical care of the pediatric immunocompromised hematology\/oncology patient","author":"S Ghafoor","year":"2019","unstructured":"Ghafoor S, James M, Goldberg J, McArthur JA (2019) Cardiac dysfunction in hematology oncology and hematopoietic cell transplant patients. Critical care of the pediatric immunocompromised hematology\/oncology patient. Springer, Cham, pp 211\u2013235"},{"issue":"6","key":"2344_CR25","doi-asserted-by":"crossref","first-page":"NP14","DOI":"10.1177\/0300891618794890","volume":"104","author":"L Vetrugno","year":"2018","unstructured":"Vetrugno L, Tomasino S, Battezzi A, Parisella L, Bernardinetti M, Bove T (2018) Cardiac tamponade and graft versus host disease: one more reason to remember. Tumori J 104(6):NP14\u2013NP16","journal-title":"Tumori J"},{"issue":"2","key":"2344_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5581\/1516-8484.20140034","volume":"36","author":"DC Ferreira","year":"2014","unstructured":"Ferreira DC, de Oliveira JS, Parisio K, Ramalho FM (2014) Pericardial effusion and cardiac tamponade: clinical manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Rev Bras Hematol Hemoter 36(2):159\u2013161","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"4","key":"2344_CR27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/bmt.2016.331","volume":"52","author":"TM Pfeiffer","year":"2017","unstructured":"Pfeiffer TM, Rotz SJ, Ryan TD, Hirsch R, Taylor M, Chima R et al (2017) Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series. Bone Marrow Transplant 52(4):630\u2013633","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2344_CR28","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2013.07.017","volume":"19","author":"CE Dandoy","year":"2013","unstructured":"Dandoy CE, Hirsch R, Chima R, Davies SM, Jodele S (2013) Pulmonary hypertension after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19(11):1546\u20131556","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2344_CR29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","volume":"54","author":"S Jodele","year":"2016","unstructured":"Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G et al (2016) New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transfus Apher Sci 54(2):181\u2013190","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"2344_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2017.08.035","volume":"24","author":"N Ovchinsky","year":"2018","unstructured":"Ovchinsky N, Frazier W, Auletta JJ, Dvorak CC, Ardura M, Song E et al (2018) Consensus report by the pediatric acute lung injury and sepsis investigators and pediatric blood and marrow transplantation consortium joint working committees on supportive care guidelines for management of veno-occlusive disease in children and adolescents, part 3: focus on cardiorespiratory dysfunction, infections, liver dysfunction, and delirium. Biol Blood Marrow Transplant 24(2):207\u2013218","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2344_CR31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","volume":"28","author":"T Murdych","year":"2001","unstructured":"Murdych T, Weisdorf DJ (2001) Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977\u20131997. Bone Marrow Transplant 28(3):283\u2013287","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2344_CR32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.bmt.1705023","volume":"36","author":"M Rhodes","year":"2005","unstructured":"Rhodes M, Lautz T, Kavanaugh-Mchugh A, Manes B, Calder C, Koyama T et al (2005) Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients. Bone Marrow Transplant 36(2):139\u2013144","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2344_CR33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","volume":"25","author":"EJ Hoorn","year":"2012","unstructured":"Hoorn EJ, Walsh SB, McCormick JA, Zietse R, Unwin RJ, Ellison DH (2012) Pathogenesis of calcineurin inhibitor-induced hypertension. J Nephrol 25(3):269\u2013275","journal-title":"J Nephrol"},{"issue":"6","key":"2344_CR34","doi-asserted-by":"crossref","first-page":"e0131394","DOI":"10.1371\/journal.pone.0131394","volume":"10","author":"T Nishikawa","year":"2015","unstructured":"Nishikawa T, Miyahara E, Kurauchi K, Watanabe E, Ikawa K, Asaba K et al (2015) Mechanisms of fatal cardiotoxicity following high-dose cyclophosphamide therapy and a method for its prevention. PLoS ONE 10(6):e0131394","journal-title":"PLoS ONE"},{"issue":"12","key":"2344_CR35","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/bmt.2017.188","volume":"52","author":"M Martin","year":"2017","unstructured":"Martin M, Fornecker LM, Marcellin L, Mousseaux E, Hij A, Snowden JA et al (2017) Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening. Bone Marrow Transplant 52(12):1674\u20131677","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2344_CR36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","volume":"141","author":"JS Gottdiener","year":"1981","unstructured":"Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J (1981) Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141(6):758\u2013763","journal-title":"Arch Intern Med"},{"issue":"6","key":"2344_CR37","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.1992.10.6.995","volume":"10","author":"LJ Ayash","year":"1992","unstructured":"Ayash LJ, Wright JE, Tretyakov O, Gonin R, Elias A, Wheeler C et al (1992) Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol 10(6):995\u20131000","journal-title":"J Clin Oncol"},{"issue":"7","key":"2344_CR38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.1991.9.7.1215","volume":"9","author":"AC Braverman","year":"1991","unstructured":"Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT (1991) Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 9(7):1215\u20131223","journal-title":"J Clin Oncol"},{"issue":"9","key":"2344_CR39","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14737140.6.9.1249","volume":"6","author":"RL Jones","year":"2006","unstructured":"Jones RL, Ewer MS (2006) Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs. Expert Rev Anticancer Ther 6(9):1249\u20131269","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"2344_CR40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bmt.1704166","volume":"32","author":"K Van Besien","year":"2003","unstructured":"Van Besien K, Devine S, Wickrema A, Jessop E, Amin K, Yassine M et al (2003) Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies. Bone Marrow Transplant 32(5):471\u2013476","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2344_CR41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1705145","volume":"36","author":"K Oshima","year":"2005","unstructured":"Oshima K, Sakata-Yanagimoto M, Asano-Mori Y, Izutsu K, Watanabe T, Shoda E et al (2005) Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab. Bone Marrow Transplant 36(9):821\u2013824","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2344_CR42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbmt.2005.07.002","volume":"11","author":"C Rackley","year":"2005","unstructured":"Rackley C, Schultz KR, Goldman FD, Chan KW, Serrano A, Hulse JE et al (2005) Cardiac manifestations of graft-versus-host disease. Biol Blood Marrow Transplant 11(10):773\u2013780","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2344_CR43","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.bmt.1704487","volume":"33","author":"M Sakata-Yanagimoto","year":"2004","unstructured":"Sakata-Yanagimoto M, Kanda Y, Nakagawa M, Asano-Mori Y, Kandabashi K, Izutsu K et al (2004) Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplant 33(10):1043\u20131047","journal-title":"Bone Marrow Transplant"},{"key":"2344_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13482","author":"R Alblooshi","year":"2020","unstructured":"Alblooshi R, Kanfar S, Lord B, Atenafu EG, Michelis FV, Pasic I et al (2020) Clinical prevalence and outcome of cardiovascular events in the first 100 days post allogeneic HSCT. Eur J Haematol. https:\/\/doi.org\/10.1111\/ejh.13482","journal-title":"Eur J Haematol"},{"issue":"6","key":"2344_CR45","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ejh.13322","volume":"103","author":"K Chiengthong","year":"2019","unstructured":"Chiengthong K, Lertjitbanjong P, Thongprayoon C, Bathini T, Sharma K, Prasitlumkum N et al (2019) Arrhythmias in hematopoietic stem cell transplantation: a systematic review and meta-analysis. Eur J Haematol 103(6):564\u2013572","journal-title":"Eur J Haematol"},{"issue":"10","key":"2344_CR46","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/cncr.30534","volume":"123","author":"CJ Lin","year":"2017","unstructured":"Lin CJ, Vader JM, Slade M, DiPersio JF, Westervelt P, Romee R (2017) Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation. Cancer 123(10):1800\u20131809","journal-title":"Cancer"},{"issue":"9","key":"2344_CR47","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/bmt.2015.127","volume":"50","author":"ES Tonorezos","year":"2015","unstructured":"Tonorezos ES, Stillwell EE, Calloway JJ, Glew T, Wessler JD, Rebolledo BJ et al (2015) Arrhythmias in the setting of hematopoietic cell transplants. Bone Marrow Transplant 50(9):1212\u20131216","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2344_CR48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428194.2014.926346","volume":"56","author":"Z Gul","year":"2015","unstructured":"Gul Z, Bashir Q, Cremer M, Yusuf SW, Gunaydin H, Arora S et al (2015) Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma. Leuk Lymphoma 56(2):533\u2013535","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2344_CR49","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ijcard.2012.06.021","volume":"167","author":"XD Mo","year":"2013","unstructured":"Mo XD, Xu LP, Liu DH, Zhang XH, Chen H, Chen YH et al (2013) Heart failure after allogeneic hematopoietic stem cell transplantation. Int J Cardiol 167(6):2502\u20132506","journal-title":"Int J Cardiol"},{"issue":"8","key":"2344_CR50","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbmt.2013.05.019","volume":"19","author":"A Singla","year":"2013","unstructured":"Singla A, Hogan WJ, Ansell SM, Buadi FK, Dingli D, Dispenzieri A et al (2013) Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 19(8):1233\u20131237","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2344_CR51","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bmt.2012.253","volume":"48","author":"JA Steuter","year":"2013","unstructured":"Steuter JA, Villanueva ML, Loberiza FR, Armitage JO, Bociek RG, Ganti AK et al (2013) Factors affecting the development of atrial fibrillation and atrial flutter (AF\/AFL) following autologous hematopoietic SCT (auto-HSCT). Bone Marrow Transplant 48(7):963\u2013965","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2344_CR52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/clc.20904","volume":"34","author":"V Feliz","year":"2011","unstructured":"Feliz V, Saiyad S, Ramarao SM, Khan H, Leonelli F, Guglin M (2011) Melphalan-induced supraventricular tachycardia: incidence and risk factors. Clin Cardiol 34(6):356\u2013359","journal-title":"Clin Cardiol"},{"issue":"8","key":"2344_CR53","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bbmt.2010.12.698","volume":"17","author":"EE Stillwell","year":"2011","unstructured":"Stillwell EE, Wessler JD, Rebolledo BJ, Steingart RM, Petrlik EL, Jakubowski AA et al (2011) Retrospective outcome data for hematopoietic stem cell transplantation in patients with concurrent coronary artery disease. Biol Blood Marrow Transplant 17(8):1182\u20131186","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2344_CR54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bmt.2009.97","volume":"45","author":"E Peres","year":"2010","unstructured":"Peres E, Levine JE, Khaled YA, Ibrahim RB, Braun TM, Krijanovski OI et al (2010) Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation. Bone Marrow Transplant 45(1):149\u2013152","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2344_CR55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.bmt.1704610","volume":"34","author":"WH Tang","year":"2004","unstructured":"Tang WH, Thomas S, Kalaycio M, Sobecks R, Andresen S, Jarvis J et al (2004) Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction? Bone Marrow Transplant 34(7):603\u2013607","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2344_CR56","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1200\/JCO.1998.16.12.3796","volume":"16","author":"SL Goldberg","year":"1998","unstructured":"Goldberg SL, Klumpp TR, Magdalinski AJ, Mangan KF (1998) Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. J Clin Oncol 16(12):3796\u20133802","journal-title":"J Clin Oncol"},{"issue":"14","key":"2344_CR57","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/bloodadvances.2018019117","volume":"2","author":"SH Armenian","year":"2018","unstructured":"Armenian SH, Yang D, Teh JB, Atencio LC, Gonzales A, Wong FL et al (2018) Prediction of cardiovascular disease among hematopoietic cell transplantation survivors. Blood Adv 2(14):1756\u20131764","journal-title":"Blood Adv"},{"issue":"1","key":"2344_CR58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-155-1-201107050-00004","volume":"155","author":"EJ Chow","year":"2011","unstructured":"Chow EJ, Mueller BA, Baker KS, Cushing-Haugen KL, Flowers ME, Martin PJ et al (2011) Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med 155(1):21\u201332","journal-title":"Ann Intern Med"},{"issue":"23","key":"2344_CR59","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","volume":"118","author":"SH Armenian","year":"2011","unstructured":"Armenian SH, Sun CL, Shannon T, Mills G, Francisco L, Venkataraman K et al (2011) Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. Blood 118(23):6023\u20136029","journal-title":"Blood"},{"issue":"10","key":"2344_CR60","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2009.06.001","volume":"15","author":"MH Qazilbash","year":"2009","unstructured":"Qazilbash MH, Amjad AI, Qureshi S, Qureshi SR, Saliba RM, Khan ZU et al (2009) Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction. Biol Blood Marrow Transplant 15(10):1265\u20131270","journal-title":"Biol Blood Marrow Transplant"},{"issue":"34","key":"2344_CR61","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1200\/JCO.2008.17.7428","volume":"26","author":"SH Armenian","year":"2008","unstructured":"Armenian SH, Sun CL, Francisco L, Steinberger J, Kurian S, Wong FL et al (2008) Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol 26(34):5537\u20135543","journal-title":"J Clin Oncol"},{"issue":"2","key":"2344_CR62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bmt.1702466","volume":"26","author":"S Lehmann","year":"2000","unstructured":"Lehmann S, Isberg B, Ljungman P, Paul C (2000) Cardiac systolic function before and after hematopoietic stem cell transplantation. Bone Marrow Transplant 26(2):187\u2013192","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2344_CR63","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.31227","volume":"124","author":"KJ Leger","year":"2018","unstructured":"Leger KJ, Baker KS, Cushing-Haugen KL, Flowers MED, Leisenring WM, Martin PJ et al (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124(7):1507\u20131515","journal-title":"Cancer"},{"issue":"5","key":"2344_CR64","first-page":"419","volume":"10","author":"A Garaventa","year":"1992","unstructured":"Garaventa A, Porta F, Rondelli R, Dini G, Meloni G, Bonetti F et al (1992) Early deaths in children after BMT. Bone marrow transplantation group of the italian association for pediatric hematology and oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant 10(5):419\u2013423","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2344_CR65","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/bmt.2017.62","volume":"52","author":"SJ Rotz","year":"2017","unstructured":"Rotz SJ, Ryan TD, Jodele S, Jefferies JL, Lane A, Pate A et al (2017) The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults. Bone Marrow Transplant 52(8):1171\u20131179","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2344_CR66","doi-asserted-by":"crossref","first-page":"e26513","DOI":"10.1002\/pbc.26513","volume":"64","author":"CE Dandoy","year":"2017","unstructured":"Dandoy CE, Jodele S, Paff Z, Hirsch R, Ryan TD, Jefferies JL et al (2017) Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients. Pediatr Blood Cancer 64(10):e26513","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2344_CR67","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/petr.12062","volume":"17","author":"O Aldoss","year":"2013","unstructured":"Aldoss O, Gruenstein DH, Bass JL, Steinberger J, Zhang Y, Defor TE et al (2013) Pericardial effusion after pediatric hematopoietic cell transplant. Pediatr Transplant 17(3):294\u2013299","journal-title":"Pediatr Transplant"},{"issue":"4","key":"2344_CR68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bmt.2010.149","volume":"46","author":"M Neier","year":"2011","unstructured":"Neier M, Jin Z, Kleinman C, Baldinger L, Bhatia M, Silver E et al (2011) Pericardial effusion post-SCT in pediatric recipients with signs and\/or symptoms of cardiac disease. Bone Marrow Transplant 46(4):529\u2013538","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2344_CR69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000091638","volume":"105","author":"A Limsuwan","year":"2006","unstructured":"Limsuwan A, Pakakasama S, Rochanawutanon M, Hong-eng S (2006) Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation. Cardiology 105(3):188\u2013194","journal-title":"Cardiology"},{"issue":"2","key":"2344_CR70","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MPH.0000000000000974","volume":"40","author":"M Diamond","year":"2018","unstructured":"Diamond M, Ruiz-Mesa C, Corrales-Medina FF, Tamariz LJ, Ziga E, Swaminathan S (2018) Incidence and outcome of pericardial effusion in pediatric patients after hematopoietic stem cell transplant: a single-institution experience. J Pediatr Hematol Oncol 40(2):132\u2013136","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"2344_CR71","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbmt.2016.02.017","volume":"22","author":"KJ Leger","year":"2016","unstructured":"Leger KJ, Cushing-Haugen K, Hansen JA, Fan W, Leisenring WM, Martin PJ et al (2016) Clinical and genetic determinants of cardiomyopathy risk among hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant 22(6):1094\u20131101","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2344_CR72","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","volume":"110","author":"A Tichelli","year":"2007","unstructured":"Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M et al (2007) Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110(9):3463\u20133471","journal-title":"Blood"},{"issue":"2","key":"2344_CR73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2016.203","volume":"52","author":"Z DeFilipp","year":"2017","unstructured":"DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL et al (2017) Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant 52(2):173\u2013182","journal-title":"Bone Marrow Transplant"},{"issue":"19","key":"2344_CR74","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1158\/1078-0432.CCR-17-3044","volume":"24","author":"CJ Gibson","year":"2018","unstructured":"Gibson CJ, Steensma DP (2018) new insights from studies of clonal hematopoiesis. Clin Cancer Res 24(19):4633\u20134642","journal-title":"Clin Cancer Res"},{"issue":"14","key":"2344_CR75","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","volume":"35","author":"CJ Gibson","year":"2017","unstructured":"Gibson CJ, Lindsley RC, Tchekmedyian V, Mar BG, Shi J, Jaiswal S et al (2017) Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. J Clin Oncol 35(14):1598\u20131605","journal-title":"J Clin Oncol"},{"issue":"2","key":"2344_CR76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E et al (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 377(2):111\u2013121","journal-title":"N Engl J Med"},{"issue":"5","key":"2344_CR77","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1200\/JCO.2018.79.2184","volume":"37","author":"M Frick","year":"2019","unstructured":"Frick M, Chan W, Arends CM, Hablesreiter R, Halik A, Heuser M et al (2019) Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation. J Clin Oncol 37(5):375\u2013385","journal-title":"J Clin Oncol"},{"issue":"4","key":"2344_CR78","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/bjh.14630","volume":"181","author":"G Collord","year":"2018","unstructured":"Collord G, Park N, Podesta M, Dagnino M, Cilloni D, Jones D et al (2018) Clonal haematopoiesis is not prevalent in survivors of childhood cancer. Br J Haematol 181(4):537\u2013539","journal-title":"Br J Haematol"},{"issue":"10","key":"2344_CR79","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/s41409-018-0155-z","volume":"53","author":"CN Duncan","year":"2018","unstructured":"Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN et al (2018) Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 53(10):1278\u20131287","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2344_CR80","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1705652","volume":"39","author":"C Uderzo","year":"2007","unstructured":"Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F et al (2007) Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT pediatric diseases and late effects working parties. Bone Marrow Transplant 39(11):667\u2013675","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2344_CR81","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1017\/S104795111800238X","volume":"29","author":"SJ Rotz","year":"2019","unstructured":"Rotz SJ, Powell A, Myers KC, Taylor MD, Jefferies JL, Lane A et al (2019) Treatment exposures stratify need for echocardiographic screening in asymptomatic long-term survivors of hematopoietic stem cell transplantation. Cardiol Young 29(3):338\u2013343","journal-title":"Cardiol Young"},{"issue":"6","key":"2344_CR82","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/bloodadvances.2019001126","volume":"4","author":"CJ Lee","year":"2020","unstructured":"Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R et al (2020) Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia. Blood Adv 4(6):983\u2013992","journal-title":"Blood Adv"},{"issue":"10","key":"2344_CR83","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/bmt.2017.162","volume":"52","author":"SJ Rotz","year":"2017","unstructured":"Rotz SJ, Dandoy CE, Taylor MD, Jodele S, Jefferies JL, Lane A et al (2017) Long-term systolic function in children and young adults after hematopoietic stem cell transplant. Bone Marrow Transplant 52(10):1443\u20131447","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2344_CR84","first-page":"363","volume":"2","author":"JM Leerink","year":"2020","unstructured":"Leerink JM, de Baat EC, Feijen EA, Bellersen L, van Dalen EC, Grotenhuis HB et al (2020) Cardiac disease in childhood cancer survivors: risk prediction, prevention, and surveillance: JACC cardiooncology state-of-the-art review. JACC: CardioOncology 2(3):363\u2013378","journal-title":"JACC: CardioOncology"},{"issue":"5","key":"2344_CR85","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2014.56.1373","volume":"33","author":"EJ Chow","year":"2015","unstructured":"Chow EJ, Chen Y, Kremer LC, Breslow NE, Hudson MM, Armstrong GT et al (2015) Individual prediction of heart failure among childhood cancer survivors. J Clin Oncol 33(5):394\u2013402","journal-title":"J Clin Oncol"},{"issue":"1","key":"2344_CR86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.2017.74.8673","volume":"36","author":"EJ Chow","year":"2018","unstructured":"Chow EJ, Chen Y, Hudson MM, Feijen EAM, Kremer LC, Border WL et al (2018) Prediction of ischemic heart disease and stroke in survivors of childhood cancer. J Clin Oncol 36(1):44\u201352","journal-title":"J Clin Oncol"},{"key":"2344_CR87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/EDBK_100015","volume":"38","author":"S Armenian","year":"2018","unstructured":"Armenian S, Bhatia S (2018) Predicting and preventing anthracycline-related cardiotoxicity. Am Soc Clin Oncol Educ Book 38:3\u201312","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"2344_CR88","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","volume":"104","author":"ML Sorror","year":"2004","unstructured":"Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C et al (2004) Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood 104(4):961\u2013968","journal-title":"Blood"},{"issue":"5","key":"2344_CR89","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","volume":"104","author":"R Diaconescu","year":"2004","unstructured":"Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG et al (2004) Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 104(5):1550\u20131558","journal-title":"Blood"},{"issue":"8","key":"2344_CR90","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912\u20132919","journal-title":"Blood"},{"issue":"5","key":"2344_CR91","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1200\/JCO.1994.12.5.998","volume":"12","author":"B Hertenstein","year":"1994","unstructured":"Hertenstein B, Stefanic M, Schmeiser T, Scholz M, Goller V, Clausen M et al (1994) Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 12(5):998\u20131004","journal-title":"J Clin Oncol"},{"issue":"3","key":"2344_CR92","first-page":"173","volume":"5","author":"SI Bearman","year":"1990","unstructured":"Bearman SI, Petersen FB, Schor RA, Denney JD, Fisher LD, Appelbaum FR et al (1990) Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant 5(3):173\u2013177","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2344_CR93","first-page":"561","volume":"17","author":"B Jain","year":"1996","unstructured":"Jain B, Floreani AA, Anderson JR, Vose JM, Robbins RA, Rennard SI et al (1996) Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality. The University of Nebraska Medical Center Bone Marrow Transplantation Pulmonary Study Group. Bone Marrow Transplant 17(4):561\u2013568","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2344_CR94","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bmt.1702234","volume":"25","author":"BE Brockstein","year":"2000","unstructured":"Brockstein BE, Smiley C, Al-Sadir J, Williams SF (2000) Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant 25(8):885\u2013894","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2344_CR95","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bbmt.2009.12.537","volume":"16","author":"J Koreth","year":"2010","unstructured":"Koreth J, Aldridge J, Kim HT, Alyea EP 3rd, Cutler C, Armand P et al (2010) Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. Biol Blood Marrow Transplant 16(6):792\u2013800","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2344_CR96","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.3324\/haematol.2015.139345","volume":"101","author":"J El Cheikh","year":"2016","unstructured":"El Cheikh J, Sfumato P, Sobh M, Fegueux N, Mohty M, Vigouroux S et al (2016) Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study from the French society for stem cell transplantation (SFGM-TC). Haematologica 101(6):e262\u2013e265","journal-title":"Haematologica"},{"issue":"23","key":"2344_CR97","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"X Bosch","year":"2013","unstructured":"Bosch X, Rovira M, Sitges M, Domenech A, Ortiz-Perez JT, de Caralt TM et al (2013) Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies). J Am Coll Cardiol 61(23):2355\u20132362","journal-title":"J Am Coll Cardiol"},{"issue":"9206","key":"2344_CR98","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(00)02051-1","volume":"355","author":"H Nakamae","year":"2000","unstructured":"Nakamae H, Tsumura K, Hino M, Hayashi T, Tatsumi N (2000) QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide. Lancet 355(9206):805\u2013806","journal-title":"Lancet"},{"issue":"1","key":"2344_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.20042","volume":"76","author":"H Nakamae","year":"2004","unstructured":"Nakamae H, Hino M, Akahori M, Terada Y, Yamane T, Ohta K et al (2004) Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation. Am J Hematol 76(1):1\u20137","journal-title":"Am J Hematol"},{"issue":"3","key":"2344_CR100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1475-097X.2009.00920.x","volume":"30","author":"T Kuittinen","year":"2010","unstructured":"Kuittinen T, Jantunen E, Vanninen E, Mussalo H, Nousiainen T, Hartikainen J (2010) Late potentials and QT dispersion after high-dose chemotherapy in patients with non-Hodgkin lymphoma. Clin Physiol Funct Imaging 30(3):175\u2013180","journal-title":"Clin Physiol Funct Imaging"},{"issue":"8","key":"2344_CR101","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/TP.0b013e3181f10edb","volume":"90","author":"BR Dey","year":"2010","unstructured":"Dey BR, Chung SS, Spitzer TR, Zheng H, Macgillivray TE, Seldin DC et al (2010) Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure. Transplantation 90(8):905\u2013911","journal-title":"Transplantation"},{"issue":"10","key":"2344_CR102","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2003-12-4192","volume":"103","author":"A Dispenzieri","year":"2004","unstructured":"Dispenzieri A, Kyle RA, Lacy MQ, Therneau TM, Larson DR, Plevak MF et al (2004) Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood 103(10):3960\u20133963","journal-title":"Blood"},{"issue":"32","key":"2344_CR103","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1200\/JCO.2015.62.4015","volume":"33","author":"A D'Souza","year":"2015","unstructured":"D\u2019Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA et al (2015) Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a center for international blood and marrow transplant research study. J Clin Oncol 33(32):3741\u20133749","journal-title":"J Clin Oncol"},{"issue":"4","key":"2344_CR104","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/bmt.2012.170","volume":"48","author":"MA Gertz","year":"2013","unstructured":"Gertz MA, Lacy MQ, Dispenzieri A, Kumar SK, Dingli D, Leung N et al (2013) Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis. Bone Marrow Transplant 48(4):557\u2013561","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2344_CR105","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","volume":"68","author":"RH Falk","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S (2016) AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol 68(12):1323\u20131341","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2344_CR106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bmt.1705401","volume":"38","author":"J Cox-Brinkman","year":"2006","unstructured":"Cox-Brinkman J, Boelens JJ, Wraith JE, O\u2019Meara A, Veys P, Wijburg FA et al (2006) Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant 38(1):17\u201321","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2344_CR107","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-012-9500-3","volume":"36","author":"DH Wiseman","year":"2013","unstructured":"Wiseman DH, Mercer J, Tylee K, Malaiya N, Bonney DK, Jones SA et al (2013) Management of mucopolysaccharidosis type IH (Hurler\u2019s syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution\u2019s experience. J Inherit Metab Dis 36(2):263\u2013270","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2344_CR108","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MAT.0000000000001002","volume":"66","author":"RD Coleman","year":"2020","unstructured":"Coleman RD, Goldman J, Moffett B, Guffey D, Loftis L, Thomas J et al (2020) Extracorporeal membrane oxygenation mortality in high-risk populations: an analysis of the pediatric health information system database. ASAIO J 66(3):327\u2013331","journal-title":"ASAIO J"},{"key":"2344_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28403","author":"DA Steppan","year":"2020","unstructured":"Steppan DA, Coleman RD, Viamonte HK, Hanson SJ, Carroll MK, Klein OR et al (2020) Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation: the PEDECOR experience. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.28403","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2344_CR110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.seminoncol.2013.01.005","volume":"40","author":"JR Carver","year":"2013","unstructured":"Carver JR, Szalda D, Ky B (2013) Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance. Semin Oncol 40(2):229\u2013238","journal-title":"Semin Oncol"},{"issue":"36","key":"2344_CR111","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M et al (2016) 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37(36):2768\u20132801","journal-title":"Eur Heart J"},{"issue":"8","key":"2344_CR112","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N et al (2017) Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of clinical oncology clinical practice guideline. J Clin Oncol 35(8):893\u2013911","journal-title":"J Clin Oncol"},{"issue":"25","key":"2344_CR113","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","volume":"65","author":"A Barac","year":"2015","unstructured":"Barac A, Murtagh G, Carver JR, Chen MH, Freeman AM, Herrmann J et al (2015) Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol 65(25):2739\u20132746","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2344_CR114","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5581\/1516-8484.20120032","volume":"34","author":"NS Majhail","year":"2012","unstructured":"Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al (2012) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Rev Bras Hematol Hemoter 34(2):109\u2013133","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"8","key":"2344_CR115","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bbmt.2016.05.007","volume":"22","author":"Z DeFilipp","year":"2016","unstructured":"DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL et al (2016) Metabolic syndrome and cardiovascular disease after hematopoietic cell transplantation: screening and preventive practice recommendations from the CIBMTR and EBMT. Biol Blood Marrow Transplant 22(8):1493\u20131503","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2344_CR116","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","volume":"22","author":"EJ Chow","year":"2016","unstructured":"Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT et al (2016) Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a children\u2019s oncology group report. Biol Blood Marrow Transplant 22(5):782\u2013795","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"2344_CR117","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(16):e147-239","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"2344_CR118","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F et al (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131(22):1981\u20131988","journal-title":"Circulation"},{"issue":"11","key":"2344_CR119","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","volume":"48","author":"N Kalay","year":"2006","unstructured":"Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A et al (2006) Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 48(11):2258\u20132262","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2344_CR120","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","volume":"60","author":"S Seicean","year":"2012","unstructured":"Seicean S, Seicean A, Plana JC, Budd GT, Marwick TH (2012) Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study. J Am Coll Cardiol 60(23):2384\u20132390","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2344_CR121","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","volume":"55","author":"D Cardinale","year":"2010","unstructured":"Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G et al (2010) Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 55(3):213\u2013220","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2344_CR122","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","volume":"33","author":"R Kirk","year":"2014","unstructured":"Kirk R, Dipchand AI, Rosenthal DN, Addonizio L, Burch M, Chrisant M et al (2014) The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary. J Heart Lung Transplant 33(9):888\u2013909","journal-title":"J Heart Lung Transplant"},{"issue":"23","key":"2344_CR123","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1200\/JCO.2002.12.102","volume":"20","author":"SE Lipshultz","year":"2002","unstructured":"Lipshultz SE, Lipsitz SR, Sallan SE, Simbre VC 2nd, Shaikh SL, Mone SM et al (2002) Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 20(23):4517\u20134522","journal-title":"J Clin Oncol"},{"issue":"5","key":"2344_CR124","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","volume":"22","author":"JH Silber","year":"2004","unstructured":"Silber JH, Cnaan A, Clark BJ, Paridon SM, Chin AJ, Rychik J et al (2004) Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 22(5):820\u2013828","journal-title":"J Clin Oncol"},{"key":"2344_CR125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ehf2.12627","volume":"7","author":"A Martin-Garcia","year":"2020","unstructured":"Martin-Garcia A, Lopez-Fernandez T, Mitroi C, Chaparro-Munoz M, Moliner P, Martin-Garcia AC et al (2020) Effectiveness of sacubitril-valsartan in cancer patients with heart failure. ESC Heart Fail 7:763\u2013767","journal-title":"ESC Heart Fail"},{"issue":"10166","key":"2344_CR126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","volume":"393","author":"BP Halliday","year":"2019","unstructured":"Halliday BP, Wassall R, Lota AS, Khalique Z, Gregson J, Newsome S et al (2019) Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet 393(10166):61\u201373","journal-title":"Lancet"},{"issue":"2","key":"2344_CR127","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbmt.2016.08.019","volume":"23","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Chemaitilly W, Chen M, Chow EJ, Duncan CN, Jones LW et al (2017) National institutes of health hematopoietic cell transplantation late effects initiative: the cardiovascular disease and associated risk factors working group report. Biol Blood Marrow Transplant 23(2):201\u2013210","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2344_CR128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrcardio.2015.133","volume":"12","author":"MS Ewer","year":"2015","unstructured":"Ewer MS, Ewer SM (2015) Cardiotoxicity of anticancer treatments. Nat Rev Cardiol 12(11):620","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"2344_CR129","doi-asserted-by":"crossref","first-page":"e26600","DOI":"10.1002\/pbc.26600","volume":"64","author":"SJ Rotz","year":"2017","unstructured":"Rotz SJ, Ryan TD, Hlavaty J, George SA, El-Bietar J, Dandoy CE (2017) Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant. Pediatr Blood Cancer 64(11):e26600","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2344_CR130","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbmt.2017.03.020","volume":"23","author":"BM Getta","year":"2017","unstructured":"Getta BM, Kishtagari A, Hilden P, Tallman MS, Maloy M, Gonzales P et al (2017) Allogeneic hematopoietic stem cell transplantation is underutilized in older patients with myelodysplastic syndromes. Biol Blood Marrow Transplant 23(7):1078\u20131086","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2344_CR131","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bbmt.2013.06.014","volume":"19","author":"S Yao","year":"2013","unstructured":"Yao S, Hahn T, Zhang Y, Haven D, Senneka M, Dunford L et al (2013) Unrelated donor allogeneic hematopoietic cell transplantation is underused as a curative therapy in eligible patients from the United States. Biol Blood Marrow Transplant 19(10):1459\u20131464","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2344_CR132","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bbmt.2013.07.026","volume":"19","author":"NS Majhail","year":"2013","unstructured":"Majhail NS, Lazarus HM (2013) Many are called but few are chosen: under-utilization of unrelated donor transplantation. Biol Blood Marrow Transplant 19(10):1414\u20131415","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02344-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:44:44Z","timestamp":1619675084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02344-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02344-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"12 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}